Regional vascular and hemodynamic effects of orally administered nisoldipine in conscious rats

Helmut Drexler, Arnold G. Truog, Robert Zelis, Stephen F. Flaim

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

This study examined the hemodynamic and regional vascular effects of orally administered nisoldipine, a new dihydropyridine derivative (0.3 mg/kg) in normal conscious rats (n = 10). Nisoldipine significantly reduced systemic vascular resistance (0.58 to 0.38 mm Hg kg min/ml, p < 0.05) and mean arterial pressure (122 to 108 mm Hg, p < 0.05), and increased heart rate (395 to 447 beats/min, p < 0.01) and cardiac index (225 to 326 ml/beat/kg, p < 0.05). Left ventricular end-diastolic pressure was slightly decreased by nisoldipine (9.6 to 3.8 mm Hg, p < 0.05). Blood flow (radioactive microspheres, 15 ± 5 μm in diameter) to heart, gut, kidney, and brain was significantly increased. Improvement of blood flow was most pronounced in the coronary circulation (+58%) followed by the gut and renal circulatory beds. We conclude that nisoldipine represents a new orally effective calcium antagonist with highly selective effects in vascular smooth muscle as compared with its direct cardiac effects. The results are compared with our previous study utilizing intravenous nisoldipine.

Original languageEnglish (US)
Pages (from-to)151-155
Number of pages5
JournalJournal of Cardiovascular Pharmacology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 1986

Fingerprint

Nisoldipine
Blood Vessels
Hemodynamics
Kidney
Coronary Circulation
Microspheres
Vascular Smooth Muscle
Vascular Resistance
Arterial Pressure
Heart Rate
Blood Pressure
Calcium
Brain

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Drexler, Helmut ; Truog, Arnold G. ; Zelis, Robert ; Flaim, Stephen F. / Regional vascular and hemodynamic effects of orally administered nisoldipine in conscious rats. In: Journal of Cardiovascular Pharmacology. 1986 ; Vol. 8, No. 1. pp. 151-155.
@article{72d3579294b0424b9e1d5c13f43c5d40,
title = "Regional vascular and hemodynamic effects of orally administered nisoldipine in conscious rats",
abstract = "This study examined the hemodynamic and regional vascular effects of orally administered nisoldipine, a new dihydropyridine derivative (0.3 mg/kg) in normal conscious rats (n = 10). Nisoldipine significantly reduced systemic vascular resistance (0.58 to 0.38 mm Hg kg min/ml, p < 0.05) and mean arterial pressure (122 to 108 mm Hg, p < 0.05), and increased heart rate (395 to 447 beats/min, p < 0.01) and cardiac index (225 to 326 ml/beat/kg, p < 0.05). Left ventricular end-diastolic pressure was slightly decreased by nisoldipine (9.6 to 3.8 mm Hg, p < 0.05). Blood flow (radioactive microspheres, 15 ± 5 μm in diameter) to heart, gut, kidney, and brain was significantly increased. Improvement of blood flow was most pronounced in the coronary circulation (+58{\%}) followed by the gut and renal circulatory beds. We conclude that nisoldipine represents a new orally effective calcium antagonist with highly selective effects in vascular smooth muscle as compared with its direct cardiac effects. The results are compared with our previous study utilizing intravenous nisoldipine.",
author = "Helmut Drexler and Truog, {Arnold G.} and Robert Zelis and Flaim, {Stephen F.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1097/00005344-198601000-00022",
language = "English (US)",
volume = "8",
pages = "151--155",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Regional vascular and hemodynamic effects of orally administered nisoldipine in conscious rats. / Drexler, Helmut; Truog, Arnold G.; Zelis, Robert; Flaim, Stephen F.

In: Journal of Cardiovascular Pharmacology, Vol. 8, No. 1, 01.01.1986, p. 151-155.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regional vascular and hemodynamic effects of orally administered nisoldipine in conscious rats

AU - Drexler, Helmut

AU - Truog, Arnold G.

AU - Zelis, Robert

AU - Flaim, Stephen F.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - This study examined the hemodynamic and regional vascular effects of orally administered nisoldipine, a new dihydropyridine derivative (0.3 mg/kg) in normal conscious rats (n = 10). Nisoldipine significantly reduced systemic vascular resistance (0.58 to 0.38 mm Hg kg min/ml, p < 0.05) and mean arterial pressure (122 to 108 mm Hg, p < 0.05), and increased heart rate (395 to 447 beats/min, p < 0.01) and cardiac index (225 to 326 ml/beat/kg, p < 0.05). Left ventricular end-diastolic pressure was slightly decreased by nisoldipine (9.6 to 3.8 mm Hg, p < 0.05). Blood flow (radioactive microspheres, 15 ± 5 μm in diameter) to heart, gut, kidney, and brain was significantly increased. Improvement of blood flow was most pronounced in the coronary circulation (+58%) followed by the gut and renal circulatory beds. We conclude that nisoldipine represents a new orally effective calcium antagonist with highly selective effects in vascular smooth muscle as compared with its direct cardiac effects. The results are compared with our previous study utilizing intravenous nisoldipine.

AB - This study examined the hemodynamic and regional vascular effects of orally administered nisoldipine, a new dihydropyridine derivative (0.3 mg/kg) in normal conscious rats (n = 10). Nisoldipine significantly reduced systemic vascular resistance (0.58 to 0.38 mm Hg kg min/ml, p < 0.05) and mean arterial pressure (122 to 108 mm Hg, p < 0.05), and increased heart rate (395 to 447 beats/min, p < 0.01) and cardiac index (225 to 326 ml/beat/kg, p < 0.05). Left ventricular end-diastolic pressure was slightly decreased by nisoldipine (9.6 to 3.8 mm Hg, p < 0.05). Blood flow (radioactive microspheres, 15 ± 5 μm in diameter) to heart, gut, kidney, and brain was significantly increased. Improvement of blood flow was most pronounced in the coronary circulation (+58%) followed by the gut and renal circulatory beds. We conclude that nisoldipine represents a new orally effective calcium antagonist with highly selective effects in vascular smooth muscle as compared with its direct cardiac effects. The results are compared with our previous study utilizing intravenous nisoldipine.

UR - http://www.scopus.com/inward/record.url?scp=0022585469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022585469&partnerID=8YFLogxK

U2 - 10.1097/00005344-198601000-00022

DO - 10.1097/00005344-198601000-00022

M3 - Article

VL - 8

SP - 151

EP - 155

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 1

ER -